Peritoneal transport characteristic is a potential survival predictor. In this study we evaluated the effect of transport characteristics on 10 year patient survival and compared its' impact with other possible survival predictors.
INTRODUCTION
Patients with end-stage renal disease (ESRD) have increased risk of premature death usually due to atherosclerosis-related diseases or infectious complications (1) . Dialysis modality might also have some impact on this risk (2) . Peritoneal dialysis (PD) patients' peritoneal transport characteristics (PTC) were also speculated to modify the well-known mortality risk factors like hyperlipidemia, malnutrition/hypoalbuminemia and chronic infl ammation (3) (4) (5) . PTC are defi ned by a peritoneal equilibration test (PET) which was standardized by Twardowski et al (6) . PD regimens are arranged according to PET which is also an useful tool for patient follow-up and diagnosis of peritoneal dysfunctions. In our recent study we analyzed 84 PD patients who were receiving PD for minimum 36 months and found that high (H) and high-average (HA) transporter peritoneal membrane characteristics were risk factors for chronic infl ammatory state (5) . A comparison between transport groups revealed that the H/HA PTC was associated with lower albumin, higher C-reactive protein (CRP) levels, and higher recombinant human erythropoietin (rHuEPO) needs in the fi rst 3 years of PD when compared with the L/LA type. Also percentage of patients who had an atherosclerosis-related event was signifi cantly higher in H/HA group (43.1% vs. 18.1%, p < 0.01). We also reported that D/P creatinine levels were in positive correlation with CRP levels, and in negative correlation with mean albumin levels. In this current study we aimed to analyze the effects of some clinical characteristics on 10-year patient and PD survival.
MATERIAL and METHODS
After the publication of previous study, 7 patients underwent kidney transplantation and 2 patients moved to another center (5) . All analyzes were performed after excluding these patients. Remaining study group size was 75 patients.
All patients were under CAPD and were receiving PD solutions (2000-2500 mL, glucose 1.36%, 2.27% or 3.86%, BaxterDianeal 137, Deerfi eld IL) four to fi ve times daily. The weeklycalculated Kt/V value was 2.0 ± 0.3 during the follow-up period. PTC were identifi ed after a PET at the third month of CAPD using the Dialysate/Plasma (D/P) reference values defi ned by Twardowski et al (4) . Patients were classifi ed according to one of four peritoneal transport types: high (H), high-average (H/ HA), low (L) and low-average (LA). Then the patients were grouped as follows; H/HA, n:48 and L/LA, n: 27 patients.
Patient charts for 10 years from the beginning of PD were retrospectively investigated for monthly creatinine, albumin, CRP, hemoglobin (Hb), total cholesterol, triglyceride, calcium, phosphorus, intact parathyroid hormone (iPTH) levels. A mean value for each parameter was recorded as "mean follow-up value" for statistical analysis. Same data at the third month of dialysis were recorded as "initial values". Patient history (etiology for dropouts and mortality) was also collected. Atherosclerosis-related mortality was defi ned as mortality due to myocardial infarction, peripheral artery disease or atherosclerotic cerebrovascular event.
Statistical Analysis
Statistical analyses were performed by using the SPSS software (Statistical Package for the Social Sciences, version 11.0, SSPS Inc, Chicago, IL, USA). Normality of data was analyzed by using a Kolmogorov-Smirnov test. All numerical variables with normal distribution were expressed as the means ± standard deviations (SD), while variables with skew distribution were expressed as medians and interquartile range (IR). Categorical variables were expressed as percentages and compared by chi-square test. Normally distributed numeric variables were analyzed by independent samples t-test and skew distributed numeric variables were compared using the Mann-Whitney U test. Survival analysis was performed by using the KaplanMeier and Cox-regression survival tests. A p-value < 0.05 was considered as statistically signifi cant.
RESULTS
There was no signifi cant difference in means of demographic and clinical characteristics of patient groups at the initiation of PD treatment (Table I ). 20 out of 75 patients were alive and still on CAPD treatment at the end of the 10-year followup period [H/HA; 7 patients, 14.6% and L/LA; 13 patients, 48.1%, p:0.002, Table II ). 12 patients were converted to the hemodialysis modality (H/HA; 11, 22.9%, L/LA; 1, 3.7%, p: 0.029). Reasons for conversion were as follows: H/HA group, insuffi cient ultrafi ltration (n:3), peritonitis (n:8, 1 fungal peritonitis, 1 tuberculosis peritonitis), 1 L/LA patient converted to hemodialysis due to peritonitis. According to Kaplan-Meier survival analysis, overall 10-year PD survival rates (including mortality and conversion to HD) were signifi cantly lower in the H/HA group ( Figure 1 , p:0.001). After excluding patients who converted dialysis modality, patient survival was still lower in H/HA group at the end of 10 years follow-up period ( Figure 2 , p:0.004). Causes of mortality were as follows; atherosclerosisrelated (coronary or cerebrovascular mortality, H/HA; 17/30 patients, L/LA; 2/13 patients), infection-related (peritonitis or other infections, septicemia, H/HA; 12/30 patients, L/LA; 10/13 patients) and colon perforation (H/HA; 1/30 patient, L/LA; 1/13 patient). Atherosclerosis-related mortality rate was signifi cantly higher in H/HA group (45.9% vs. 7.6%, p: 0.043, Figure 3 ).
Mean albumin levels were signifi cantly higher in L/LA group (3.63 ± 0.32 vs. 3.42 ± 0.42 g/dL, p:0.026) while there was no signifi cant difference in means of CRP levels [13.3 (12.7) vs. 10 (14) mg/L, p: 0.834]. Percentage of patients with mean albumin level ≤ 3.5 g/dL was also higher in H/HA group [n: 26 (54.2%) vs. n:8 (29.6%), p:0.04, Table II ]. Percentage of patients with chronic infl ammation (mean CRP level > 10 mg/L) were similar (n:27/48, 56.3% vs. n:14/27, 51.9%, p: 0.713). Other follow-up biochemical parameters were similar (Table II) .
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Tutal E et al : High Transporter Characteristic is an Important 10-Year Survival Predictor conversion to HD, Table III) . However, further analysis revealed that hypoalbuminemia (p: 0.0001) and increased Ca x P levels (p: 0.0001) were the main survival predictors.
A Cox regression analysis revealed that hypoalbuminemia (< 3.5 g/dL), increased CaxP product levels (> 55), chronic infl ammation, H/HA peritoneal transport status were independent predictors of overall PD survival (including mortality and group. Atherosclerosis-related mortality was also signifi cantly higher in H/HA patients. We also found that H/HA patients had lower albumin levels and hypoalbuminemia (< 3.5 g/dL) was also more frequent in these patients. There was a tendency for hyperphosphatemia and increased CaxP product levels in the
DISCUSSION
In this study we found that H/HA PTC is associated with decreased PD and patient survival in 10 years follow-up period. Main reasons of PD to HD conversion were insuffi cient ultrafi ltration and peritonitis-related complications in H/HA (5) . Several studies also have reported that low serum albumin is a predictor of mortality in CAPD population (9) (10) (11) . In the current study we found that hypoalbuminemia (<3.5 mg/dl) was signifi cantly more frequent in the H/HA group and serum albumin levels were one of the main predictors of PD survival with increased CaxP product levels. Low serum albumin usually refl ects poor nutritional status and underlying chronic infl ammation; one should therefore be extra careful about the nutritional support of these patients.
In stage 5 chronic kidney disease patients, high levels of plasma calcium, serum phosphate, and iPTH play a critical role in the pathogenesis of cardiovascular events (19) and the mechanism underlying this cardiovascular risk appears to be a direct effect of arterial calcifi cation. There is strong evidence that vascular calcifi cation is closely associated with high serum Ca and P levels and a high serum Ca x P product (20) . According to our fi ndings there was no signifi cant difference between groups in means of Ca, P and CaxP levels. However all 11 patients (9 in H/ HA group) who had a mean CaxP level > 55 lost their lives due to atherosclerosis-related events, in conformance with previous reports (19, 20) .
In current study, we found that the atherosclerosis-related mortality rate was higher in H/HA group than L/LA group (45.9% vs. 7.6%, p: 0.043, Figure-3 ). It has already been reported that volume expansion and patients with symptomatic fl uid retention are more likely to be high than low transporter (7, 8, 15) . Consequently, this higher mortality rate might be due to excess overhydration in the H/HA group. The malnutrition-infl ammation-atherosclerosis complex syndrome (MICS) is another well-defi ned risk factor for mortality in ESRD patients. In MICS there is a tendency of concurrence of malnutrition, hypoalbuminemia and chronic infl ammation, H/HA group compared to L/LA patients but without statistical signifi cance (Table II) . A regression analysis revealed that H/ HA PTC has a signifi cant negative impact on survival with hypoalbuminemia, increased CaxP and chronic infl ammation.
Survival of ESRD patients is signifi cantly lower than normal population. Factors associated with increased mortality were extensively studied by nephrologists and some signifi cant factors like chronic infl ammation, hypoalbuminemia with/ without clinical malnutrition, hyperphosphatemia, increased CaxP product levels, severe anemia are already defi ned as factors associated with all-cause and atherosclerosis-related mortality (5, (7) (8) (9) (10) (11) (12) . The preferred dialysis modality might also have an effect on mortality risk as some complications are known to be associated with only HD while some with only PD such as central venous catheter infections and sclerosing peritonitis respectively. PTC is one of these modality-specifi c conditions that might have an impact on survival rates of PD patients (13) (14) (15) (16) (17) .
The PTC, which is defi ned by a standardized PET at the initiation of PD, gives the clinician important data that affect PD modality choice and also provides a clue about possible complications that can be seen in the patient during the follow-up period (6) . The H/HA characteristic is associated with increased clearance but also with decreased ultrafi ltration rates while the L/LA characteristic is associated with excellent ultrafi ltration but low dialysis effi ciency. Guidelines encourage clinicians to use HD (in patients with high body surface area) or high dose CAPD in L/LA to increase low clearance rates. On the other hand to increase ultrafi ltration rates; an automated PD device (APD) is usually advised in H/HA patients. Despite increased UF rates with APD, H/HA patients are still under risk of hypoalbuminemia and protein malnutrition due to increased peritoneal protein clearance (5, 15) .
Supporting our fi ndings, in the CANUSA study, Churchill et al. reported that the 2-year patient survival probabilities were 91%, 80%, 72% and 71 % for L, LA, H and HA groups, respectively (15) . Similarly, in a meta-analysis, Brimble et al. reported that high transport status is associated with increased mortality rates (16) . Rumsfeld et al. analyzed survival in 5170 PD patients and reported that high PTC is a highly signifi cant and an independent risk factor for mortality (17) .
The exact mechanisms for the poorer survival of H/HA transporters remain unclear. This might be a result of an increased albumin loss, hypoalbuminemia, low ultrafi ltration rates, chronic infl ammation and increased oxidative stress (15) (16) (17) (18) . Malnutrition and hypoalbuminemia are already well known complications of H/HA transport status (5). Two most possible explanations for higher malnutrition rates are increased absorption of glucose from dialysis fl uid, leading to suppression of appetite, and increased protein losses. In our recent study we reported that H/HA transport status was associated with all factors increasing risk for atherosclerosis-related mortality.
In our previous study we found that chronic infl ammation and hypoalbuminemia were more frequent in the H/HA group in the fi rst 3-year follow-up period (5) . In this study we also found both conditions still continue in the H/HA group in the 10-year follow-up period and both have an important impact on mortality rates along with transport characteristic (Table II, III) .
In conclusion, this study suggests that H/HA transporters have a signifi cant survival disadvantage due to direct and indirect effects of PTC on well known mortality risk factors like hypoalbuminemia and chronic infl ammation. Despite these fi ndings, hypoalbuminemia and increased CaxP levels seem to be the major survival predictors. Based on these fi ndings, we suggest that H/HA patients should be under close followup for hypoalbuminemia, malnutrition, hypervolemia and atherosclerosis-related diseases and these comorbidities should be treated in early stages for better patient survival.
